Page last updated: 2024-08-23

paclitaxel and Mast-Cell Leukemia

paclitaxel has been researched along with Mast-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, YU; Choi, WK; Jang, S; Park, CJ; Seo, EJ; You, E	1

Other Studies

1 other study(ies) available for paclitaxel and Mast-Cell Leukemia

Article	Year
The First Case of Therapy-Related Myelomastocytic Leukemia Based on the WHO 2008 Classification and the Recently Proposed Diagnostic Criteria. Annals of laboratory medicine, 2017, Volume: 37, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Female; Humans; Immunophenotyping; Karyotype; Leukemia, Mast-Cell; Middle Aged; Ovarian Neoplasms; Paclitaxel; World Health Organization	2017

Article

Year

The First Case of Therapy-Related Myelomastocytic Leukemia Based on the WHO 2008 Classification and the Recently Proposed Diagnostic Criteria.

Annals of laboratory medicine, 2017, Volume: 37, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Female; Humans; Immunophenotyping; Karyotype; Leukemia, Mast-Cell; Middle Aged; Ovarian Neoplasms; Paclitaxel; World Health Organization

2017